Publications

CD38 in Advanced Prostate Cancers

Guo, C., Crespo, M., Gurel, B., Dolling, D., Rekowski, J., Sharp, A., Petremolo, A., Sumanasuriya, S., Rodrigues, D. N., Ferreira, A., Pereira, R., Figueiredo, I., Mehra, N., Lambros, M., Neeb, A., Gil, V., Seed, G., Terstappen, L., Alimonti, A., Drake, C. G., … International SU2C PCF Prostate Cancer Dream Team (2021). CD38 in Advanced Prostate Cancers. European urology, 79(6), 736–746. https://doi.org/10.1016/j.eururo.2021.01.017

CD38 in Advanced Prostate Cancers Read More »

Murine astrovirus tropism for goblet cells and enterocytes facilitates an IFN-λ response in vivo and in enteroid cultures

Ingle, H., Hassan, E., Gawron, J., Mihi, B., Li, Y., Kennedy, E. A., Kalugotla, G., Makimaa, H., Lee, S., Desai, P., McDonald, K. G., Diamond, M. S., Newberry, R. D., Good, M., & Baldridge, M. T. (2021). Murine astrovirus tropism for goblet cells and enterocytes facilitates an IFN-λ response in vivo and in enteroid cultures. Mucosal immunology, 14(3), 751–761. https://doi.org/10.1038/s41385-021-00387-6

Murine astrovirus tropism for goblet cells and enterocytes facilitates an IFN-λ response in vivo and in enteroid cultures Read More »

The impact of influenza pulmonary infection and inflammation on vagal bronchopulmonary sensory neurons

Verzele, N., Chua, B. Y., Law, C. W., Zhang, A., Ritchie, M. E., Wightman, O., Edwards, I. N., Hulme, K. D., Bloxham, C. J., Bielefeldt-Ohmann, H., Trewella, M. W., Moe, A., Chew, K. Y., Mazzone, S. B., Short, K. R., & McGovern, A. E. (2021). The impact of influenza pulmonary infection and inflammation on vagal bronchopulmonary sensory neurons. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 35(3), e21320. https://doi.org/10.1096/fj.202001509R

The impact of influenza pulmonary infection and inflammation on vagal bronchopulmonary sensory neurons Read More »

SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation

Redin, E., Garmendia, I., Lozano, T., Serrano, D., Senent, Y., Redrado, M., Villalba, M., De Andrea, C. E., Exposito, F., Ajona, D., Ortiz-Espinosa, S., Remirez, A., Bertolo, C., Sainz, C., Garcia-Pedrero, J., Pio, R., Lasarte, J., Agorreta, J., Montuenga, L. M., & Calvo, A. (2021). SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation. Journal for immunotherapy of cancer, 9(3), e001496. https://doi.org/10.1136/jitc-2020-001496

SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation Read More »

Endoderm and Hepatic Progenitor Cells Engraft in the Quiescent Liver Concurrent with Intrinsically Activated Epithelial-to-Mesenchymal Transition

Fagg, W. S., Liu, N., Patrikeev, I., Saldarriaga, O. A., Motamedi, M., Popov, V. L., Stevenson, H. L., & Fair, J. H. (2021). Endoderm and Hepatic Progenitor Cells Engraft in the Quiescent Liver Concurrent with Intrinsically Activated Epithelial-to-Mesenchymal Transition. Cell transplantation, 30, 963689721993780. https://doi.org/10.1177/0963689721993780

Endoderm and Hepatic Progenitor Cells Engraft in the Quiescent Liver Concurrent with Intrinsically Activated Epithelial-to-Mesenchymal Transition Read More »

Characterization of a recombinant gorilla-adenovirus HPV therapeutic vaccine (PRGN-2009)

Pellom, S. T., Smalley Rumfield, C., Morillon, Y. M., 2nd, Roller, N., Poppe, L. K., Brough, D. E., Sabzevari, H., Schlom, J., & Jochems, C. (2021). Characterization of recombinant gorilla adenovirus HPV therapeutic vaccine PRGN-2009. JCI insight, 6(7), e141912. https://doi.org/10.1172/jci.insight.141912

Characterization of a recombinant gorilla-adenovirus HPV therapeutic vaccine (PRGN-2009) Read More »

Galectin-3 inhibition with belapectin combined with anti-OX40 therapy reprograms the tumor microenvironment to favor anti-tumor immunity

Sturgill, E. R., Rolig, A. S., Linch, S. N., Mick, C., Kasiewicz, M. J., Sun, Z., Traber, P. G., Shlevin, H., & Redmond, W. L. (2021). Galectin-3 inhibition with belapectin combined with anti-OX40 therapy reprograms the tumor microenvironment to favor anti-tumor immunity. Oncoimmunology, 10(1), 1892265. https://doi.org/10.1080/2162402X.2021.1892265

Galectin-3 inhibition with belapectin combined with anti-OX40 therapy reprograms the tumor microenvironment to favor anti-tumor immunity Read More »